The HHS issued a final rule updating outdated regulations to provide enhanced protection for clinical research participants – and the FDA may follow suit.
Technology is catapulting clinical trials into a 'new era' as scientific breakthroughs bring new opportunities to an industry that has traditionally lacked innovation.
Poor communication between healthcare providers and clinical research professionals is contributing to low recruitment rates, according to a recent study by Tufts.
Parexel’s restructuring plan to ‘simplify the organization’ will include eliminating an undisclosed amount of positions as the CRO looks to save on costs.
Pharmaron’s acquisition of Xceleron further supports early discovery, preclinical and clinical development with expanded radiolabeled sciences capabilities.
In an exclusive licensing agreement with Merck & Co Inc (MSD), Cerveau will take on development of the firm’s investigative PET imaging agent up to Phase III trials for Alzheimer’s Disease.
Worldwide Clinical Trials will support the full scope of Renova Therapeutics Phase III trial for its lead gene therapy product candidate, says the CRO.
Turnover in the US for clinical monitoring jobs at contract research organizations (CROs) has remained high despite efforts to increase salaries, according to a recent report.
Total spending on medicines is expected to reach $1.5 trillion by 2021, up 33% from 2016 – with historical amounts of new medicines emerging from the pipeline, according to a recent report by QuintilesIMS Institute.
Earlier this week, INC Research announced its intent to expand at its headquarters in Wake County, creating 550 jobs over the next several years as part of a $37.9m investment.
As part of its collaboration with the National Institutes of Health (NIH) in the DNA vaccine clinical trial for the Zika virus, PharmaJet is providing its Stratis Needle-Free device and training to the NIH.
Almac Clinical Technologies, part of the Almac Group, has announced a strategic partnership with the contract research organization (CRO) inVentiv Health.
UK based clinical research organization (CRO), Ergomed, has bought out the Czech PharmInvent as a ‘bolt on’ to its own pharmacovigilance subsidiary, PrimeVigilance.
Global central laboratory and early development services provider, LabConnect, has launched a new data integration service to help streamline data collection and management for sponsors.
Wearable technology has been making inroads in the clinical trial industry, however several challenges and concerns surrounding lack of experience still stand in the way of increased adoption.
Clinical Ink has announced the latest release of SureSource Engage, which enables clinical trial sponsors and contract research organizations (CROs) to increase patient adherence.
The new collaborative initiative will be led by QuintilesIMS, with founding partners including Bristol-Myers Squibb, Eli Lilly and Company, Merck KGaA, and Pfizer.
Cellectar Biosciences has announced INC Research as its contract research organization (CRO) for the company’s Phase II trial of CLR 131 in hematologic malignancies.
An increase in resources dedicated to pediatric drug development is proving promising in the industry, according to a new analysis completed by the Tufts Center for the Study of Drug Development.
inVentiv Health announced last week that it has closed its previously announced transaction agreement with the private equity firm, Advent International.
Addressing training methodologies will ‘go a long way’ in improving investigator satisfaction, according to a recent survey by Worldwide Clinical Trials.
Analysts suggest a Trump presidency won’t have a material impact on contract research organizations – though a shake-up in trade policy could complicate the larger, global pharmaceutical industry.
CSSi LifeSciences has launched its fully integrated medical device contract research organization (CRO) as an alternative to “traditional ‘big-box’ CROs.”
Litmus Health imagines a future where all the world is “one big clinical trial,” and as the first step, it has launched its clinical data science platform into public beta.
Clinerion’s Patient Recruitment System (PRS) allows sponsors and clinical trial managers to identify and approach potential patients for enrollment using electronic medical records.
Significant differences in large molecule clinical trials highlights the need to be more efficient, according to a recent analysis of clinical trial duration.
With a tax incentive program making clinical trials up to 60% more cost-effective, Australia is a “gateway” to larger studies throughout Asia, says CRO.
The Chinese Food and Drug Administration (CDFA) has fired back on lack of context in media reporting “80% of China’s clinical trial data are fraudulent.”
EAG Laboratories has added 33,000-square-feet to its Easton, Maryland facility, with space for dedicated laboratories and equipment to support GLP-compliant ecotoxicology, environmental fate, metabolism, and other testing services.
The Society for Clinical Research Sites recently awarded QuintilesIMS with the 2016 Eagle Award, which recognizes contract research organizations (CRO) and sponsors focusing on site relationships.
